Primary Job Title Co-Founder and Managing Director Primary Organization 
Genesys Capital
Location Toronto, Ontario, Canada Regions Great Lakes Gender Male
LinkedIn View on LinkedIn
Mr. Holman is co-Founder and Managing Director of Genesys Capital and has extensive commercial and technical experience in the biotechnology industry. Since co-founding Genesys Capital in 2000, Mr. Holman has been actively involved in raising over $225 million of venture capital and has been instrumental in deploying over $140 million across 28
investments. He currently serves on the Board of Directors of Functional Neuromodulation Ltd. and ImpoPharma Inc. From 2001 to 2013, he served on the board of Epocal, a Genesys portfolio company recently acquired by Alere (NYSE: ALR). Mr. Holman is active in deal origination and company creation and has advised Canada's National Biotechnology Advisory Committee on strategies for financing start-up and early-stage biotechnology companies.
Prior to co-founding Genesys Capital, Mr. Holman was a Senior Investment Manager with MDS Capital Corp. During his tenure at MDS, he was involved in all stages of investment from start-up and early-stage to mezzanine stage and public company investing.
Previously, Mr. Holman worked in the laboratory of Dr. Peter St George-Hyslop at the University of Toronto where he was a key member of the international research team that discovered several genes responsible for Alzheimer's disease. Mr. Holman holds a Bachelor of Science (Honours) in Biochemistry and an MBA, both from Queen's University.
